Next-Gen Drug Conjugates Bank €46M in Series B with American Investors
Bicycle Therapeutics has closed a massive fundraising round, raking in £40M (€46M) from American investors to…
June 1, 2017 - 3 minutes
Antibody-drug conjugates
Check out the latest antibody-drug conjugate news. This section covers the latest updates on approvals, regulations, deals, and antibody–drug conjugate (ADC) technology.
What are the Current Challenges in the Booming Field of ADCs?
ADCs are overcoming the challenges of first generations and returning with a vengeance. I attended the…
February 24, 2017 - 5 minutes
In the Age of Biological Therapeutics, Chemists move to ADCs
Career options for chemists are shrinking in the shift towards biological drugs. But as antibody-drug…
February 23, 2017 - 4 minutes
10 Hot European Biotechs to Observe in 2017 🚀
New year, new list: here are the 10 hottest Biotech companies I will watch closely…
January 3, 2017 - 5 minutes
Investors bid on Nordic Nanovector’s Hottest Cancer Antibodies
Nordic Nanovector has bagged €55M to push its pipeline forward through the clinic. Investors seem to…
December 7, 2016 - 2 minutes
Another Pharma sloughs off Small Molecules to focus on Biologics
BI has taken an axe to its small molecule discovery program in order to focus…
December 5, 2016 - 2 minutes
Better than ADCs? AstraZeneca bids for Bicyclic Peptides
AstraZeneca has signed a deal with Bicycle Therapeutics that could exceed €1B. The foundation is…
December 2, 2016 - 2 minutes
Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer
PharmaMar announced positive preclinical results for an ADC candidate, showing that the traditional chemistry-based pharma…
December 1, 2016 - 2 minutes
The ABCs of ADCs: A Review of Antibody Drug Conjugates
Antibody therapies have a little sister who is catching up in funding - and hype?…
November 29, 2016 - 8 minutes
Can this new Antibody-Drug Conjugate Collaboration make it to the Top?
Nordic Nanovector is collaborating with Heidelberg Pharma to access the promising antibody-drug conjugate (ADC) technology. However,…
October 26, 2016 - 2 minutes
And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!
AstraZeneca has contributed to ADC Therapeutics' €96M fundraising, the biggest round so far in Europe…
October 19, 2016 - 3 minutes
#BioFigures: €406 Million Antibody-drug conjugate Deal struck by ImmunoGen andTakeda
WHO? ImmunoGen is a biotechnology company that develops targeted anticancer therapeutics using its state-of-the-art antibody-drug conjugate…
March 30, 2015 - 3 minutes
